Skip to main content

Peer Review reports

From: The role of vasoactive intestinal peptide (VIP) in atropine-related inhibition of the progression of myopia

Original Submission
7 Dec 2022 Submitted Original manuscript
13 Dec 2022 Author responded Author comments - Yunchun Zou
24 May 2023 Reviewed Reviewer Report
7 Jun 2023 Reviewed Reviewer Report - Ibrahim Tuncer
13 Jun 2023 Reviewed Reviewer Report
26 Jun 2023 Author responded Author comments - Yunchun Zou
Resubmission - Version 2
13 Dec 2022 Submitted Manuscript version 2
28 Jun 2023 Author responded Author comments - Yunchun Zou
Resubmission - Version 3
28 Jun 2023 Submitted Manuscript version 3
29 Jun 2023 Author responded Author comments - Yunchun Zou
Resubmission - Version 4
29 Jun 2023 Submitted Manuscript version 4
2 Jul 2023 Reviewed Reviewer Report
17 Jul 2023 Reviewed Reviewer Report
24 Jul 2023 Author responded Author comments - Yunchun Zou
Resubmission - Version 5
24 Jul 2023 Submitted Manuscript version 5
14 Aug 2023 Reviewed Reviewer Report
13 Sep 2023 Author responded Author comments - Yunchun Zou
Resubmission - Version 6
13 Sep 2023 Submitted Manuscript version 6
29 Sep 2023 Reviewed Reviewer Report
12 Oct 2023 Author responded Author comments - Yunchun Zou
Resubmission - Version 7
12 Oct 2023 Submitted Manuscript version 7
24 Oct 2023 Reviewed Reviewer Report
1 Dec 2023 Author responded Author comments - Yunchun Zou
Resubmission - Version 8
1 Dec 2023 Submitted Manuscript version 8
1 Dec 2023 Author responded Author comments - Yunchun Zou
Resubmission - Version 9
1 Dec 2023 Submitted Manuscript version 9
Publishing
16 Jan 2024 Editorially accepted
26 Jan 2024 Article published 10.1186/s12886-024-03309-9

You can find further information about peer review here.

Back to article page